Resistance of leukemia cells to contemporary chemotherapy is one of the most formidable obstacles to treating acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. Now researchers at Children's Hospital ...
Jan 26, 2015
0
83
College of Nursing colleagues Ellyn Matthews, PhD, RN, AOCNS, CBSM, Madalynn Neu, PhD, RN, and Paul Cook, PhD, have published research findings on sleep among children with acute lymphoblastic leukemia (ALL) and their mothers.
Dec 17, 2014
0
0
Common variations in four genes related to brain inflammation or cells' response to damage from oxidation may contribute to the problems with memory, learning and other cognitive functions seen in children treated for acute ...
Dec 9, 2014
0
0
Results from a large, prospective clinical trial add to mounting evidence that adolescent and young adult patients—aged 16 to 39 with acute lymphoblastic leukemia (ALL)—tend to fare better when treated with high-intensity ...
Dec 7, 2014
0
0
An innovative cell therapy against a highly aggressive form of acute lymphoblastic leukemia (ALL) continues to show highly promising results in children treated in a pilot study. Ninety-two percent of the 39 children receiving ...
Dec 6, 2014
0
0
(HealthDay)—Blincyto (blinatumomab) has been approved by the U.S. Food and Drug Administration to treat Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukemia, a rare cancer of the bone marrow.
Dec 3, 2014
0
0
Fatih Uckun, Jianjun Cheng and their colleagues have taken the first steps towards developing a so-called "smart bomb" to attack the most common and deadly form of childhood cancer—called B-lineage acute lymphoblastic leukemia ...
Nov 5, 2014
0
0
Obese youths with acute lymphoblastic leukemia (ALL) are known to have worse outcomes than their lean counterparts. To find out why, investigators at Children's Hospital Los Angeles studied patients who were obese at the ...
Oct 27, 2014
0
0
Researchers at NYU Langone Medical Center conclude new drug in development may offer first alternative to standard chemotherapy for T-Cell Acute Lymphoblastic Leukemia.
Oct 20, 2014
0
0
(HealthDay)—An experimental immune-system therapy can often lead to complete remission in advanced acute lymphoblastic leukemia (ALL) patients who have run out of other options, according to research published in the Oct. ...
Oct 16, 2014
0
0
